Literature DB >> 27460015

Safety, efficacy, and patient-perceived satisfaction of peripherally inserted central catheters in terminally ill cancer patients: a prospective multicenter observational study.

Kwonoh Park1,2, Hyun Jung Jun3, So Yeon Oh4.   

Abstract

PURPOSE: The purpose of this study was to investigate the safety, efficacy, and subjective satisfaction of peripherally inserted central catheters (PICCs) in terminally ill cancer patients.
METHODS: All PICCs were inserted by an interventional radiologist with radiological guidance. We monitored the occurrence of PICC-related complication and evaluated the patient-perceived satisfaction for PICC using semi-structured questionnaire.
RESULTS: A total of 36 terminally ill cancer patients underwent PICC. Three patients had 2 PICC insertions; hence, finally 39 episodes during 829 PICC days were analyzed. All procedures were completed without any procedure-related complication. The median catheter life span was 19.0 days (95 % CI, 14.1-23.9). Thirty-four cases maintained the PICC until the intended time, while the other 5 cases (12.8 %; 6.1/1000 PICC days) were premature PICC removals. Totally 10 complications (25.6 %; 12.3/1000 PICC days) were reported including premature removals (n = 5), trivial bleedings (n = 3), and thrombophlebitis (n = 2). Patients reported that the procedure was not distressing (42 %), a little distressing (36 %), or distressing (21 %). Of 30 patients who had preserved cognitive function at fifth day, most patients (n = 25, 83 %) reported more comfort although the other 5 patients reported no change (n = 3) or less comfort (n = 2).
CONCLUSIONS: PICCs were safely inserted and showed favorable maintenance rate with acceptable complications. Additionally, most of the patients felt that parenteral access became much comfortable after PICC insertion. When considering the characteristics of terminally ill cancer patients, poor general condition and a limited period of survival, PICC could be a safe and effective method for intravenous access.

Entities:  

Keywords:  Intravenous access; Palliative care; Peripherally inserted central catheter; Terminally ill cancer patients

Mesh:

Year:  2016        PMID: 27460015     DOI: 10.1007/s00520-016-3360-6

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  18 in total

Review 1.  The microintroducer technique for peripherally inserted central catheter placement.

Authors:  G E Sansivero
Journal:  J Intraven Nurs       Date:  2000 Nov-Dec

Review 2.  Preventing complications of central venous catheterization.

Authors:  David C McGee; Michael K Gould
Journal:  N Engl J Med       Date:  2003-03-20       Impact factor: 91.245

3.  Peripherally inserted central catheters revisited.

Authors:  J R Smith; M L Friedell; M L Cheatham; S P Martin; M J Cohen; J D Horowitz
Journal:  Am J Surg       Date:  1998-08       Impact factor: 2.565

4.  Quality of life in terminal care--with special reference to age, gender and marital status.

Authors:  C Lundh Hagelin; Ake Seiger; C J Fürst
Journal:  Support Care Cancer       Date:  2005-09-28       Impact factor: 3.603

5.  Patients' and relatives' perceptions about intravenous and subcutaneous hydration.

Authors:  Sebastiano Mercadante; Patrizia Ferrera; Davide Girelli; Alessandra Casuccio
Journal:  J Pain Symptom Manage       Date:  2005-10       Impact factor: 3.612

6.  Peripherally inserted central catheters in general medicine.

Authors:  P K Ng; M J Ault; A G Ellrodt; L Maldonado
Journal:  Mayo Clin Proc       Date:  1997-03       Impact factor: 7.616

7.  Patient-reported usefulness of peripherally inserted central venous catheters in terminally ill cancer patients.

Authors:  Rie Yamada; Tatsuya Morita; Eiko Yashiro; Hiroyuki Otani; Koji Amano; Yo Tei; Satoshi Inoue
Journal:  J Pain Symptom Manage       Date:  2010-07       Impact factor: 3.612

8.  High rate of complications associated with peripherally inserted central venous catheters in patients with solid tumours.

Authors:  K Cheong; D Perry; C Karapetis; B Koczwara
Journal:  Intern Med J       Date:  2004-05       Impact factor: 2.048

9.  Safety and effectiveness of central venous catheterization in patients with cancer: prospective observational study.

Authors:  Hyun Jung Kim; Jina Yun; Han Jo Kim; Kyoung Ha Kim; Se Hyung Kim; Sang-Cheol Lee; Sang Byung Bae; Chan Kyu Kim; Nam Su Lee; Kyu Taek Lee; Seong Kyu Park; Jong-Ho Won; Hee Sook Park; Dae Sik Hong
Journal:  J Korean Med Sci       Date:  2010-11-24       Impact factor: 2.153

10.  Patient's Factors at Entering Hospice Affecting Length of Survival in a Hospice Center.

Authors:  Guk Jin Lee; Hye Shin Ahn; Se Eun Go; Ji Hyun Kim; Min Wu Seo; Seung Hun Kang; Yeo Ree Yang; Mi Yeong Lee; Ku Ock Lee; Sang Hoon Chun; Jong Youl Jin
Journal:  Cancer Res Treat       Date:  2014-08-28       Impact factor: 4.679

View more
  4 in total

1.  What do patients say about their experience with urinary catheters and peripherally inserted central catheters?

Authors:  Barbara W Trautner; Sanjay Saint; Karen E Fowler; John Van; Tracey Rosen; John Colozzi; Vineet Chopra; Erica Lescinskas; Sarah L Krein
Journal:  Am J Infect Control       Date:  2019-07-16       Impact factor: 2.918

2.  Patient experiences with peripherally inserted venous catheters- A cross-sectional, multicentre study in Norway.

Authors:  Ann-Chatrin Linqvist Leonardsen; Ellen Marie Lunde; Stine Thorvaldsen Smith; Gitte Lise Olsen
Journal:  Nurs Open       Date:  2020-01-22

3.  Option of Using Peripherally Inserted Central Catheters in Elderly Patients With Dementia: An Observational Study.

Authors:  Yoshihisa Nakano; Takahisa Kondo; Toyoaki Murohara; Kazunobu Yamauchi
Journal:  Gerontol Geriatr Med       Date:  2020-02-18

4.  Safety, Efficacy, and Patient Satisfaction with Initial Peripherally Inserted Central Catheters Compared with Usual Intravenous Access in Terminally Ill Cancer Patients: A Randomized Phase II Study.

Authors:  Eun Ju Park; Kwonoh Park; Jae-Joon Kim; Sang-Bo Oh; Ki Sun Jung; So Yeon Oh; Yun Jeong Hong; Jin Hyeok Kim; Joo Yeon Jang; Ung-Bae Jeon
Journal:  Cancer Res Treat       Date:  2020-12-22       Impact factor: 4.679

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.